# Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

> **NCT00255749** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 89 (actual)

## Conditions studied

- Anemia
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** epoetin alfa

## Key facts

- **NCT ID:** NCT00255749
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-04
- **Final completion:** —
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2012-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255749, "Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00255749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*